Four episodes into its second season, FX’s The Strain has been renewed for a third season according to Deadline. 

The American horror series based on the Guillermo del Toro and Chuck Hogan novel of the same name premiered on FX in July of 2014. In the show’s first season, it was the number one new television series among young adults. While its second season is down in ratings, the audiences are still strong. The second episode in its sophomore season had about 2.6 million viewers. So the pickup does not come as a surprise to fans with the second season averaging at about 3.1 million viewers a week.

Carlton Cuse, one of the show’s executive producers, talked about his idea for The Strain, “The plan is that the show will run somewhere between three and five seasons… We’re writing to an endpoint, following the path as established in the novels” (TV Line).

FX’s Eric Schier made a statement about the renewal, saying, “Guillermo and Carlton have delivered two thrilling seasons of The Strain that are captivating and visually arresting, doing justice to the original novel trilogy and meeting fans’ high expectations in the process ” (Variety).

The Strain stars Corey Stoll (House of Cards), David Bradley (Game of Thrones), and Mía Maestro (Alias). The show follows Dr. Ephraim (Stoll), a doctor for the Center of Disease Control, and his team are sent to investigate a recent outbreak that could destroy humanity. In its second season, New York has fallen into disorder because of the epidemic and Dr. Ephraim and his team are still trying to save the world from the outbreak.

You can continuing watching the second season of FX’s The Strain on Sundays.